BackShukra Pharmaceuticals Limited Overview
Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited P/E Ratio

Valuation check: SHUKRAPHAR.BO's P/E ratio is 81.44, above the sector sector average of 22.49.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

81.44

P/E Ratio

81.44

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) FAQ

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) currently reports a P/E ratio of 81.44. That is above the sector sector average of 22.49. Use the charts on this page to explore Shukra Pharmaceuticals Limited's P/E ratio history and peer comparisons.

Shukra Pharmaceuticals Limited's P/E ratio of 81.44 is higher than the its sector sector average of 22.49. That is roughly 262.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Shukra Pharmaceuticals Limited's market price to a fundamental measure such as earnings, sales, or book value. At 81.44, SHUKRAPHAR.BO can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 81.44, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 22.49. From there, open related valuation or income-statement pages for Shukra Pharmaceuticals Limited, and consider following SHUKRAPHAR.BO for alerts when major investors trade the stock.

Questions & Answers